Biological significance of HLA locus matching in unrelated donor bone marrow transplantation

Blood

Volumn 125, Issue 7, 2015, Pages 1189-1197

  Morishima, Yasuo ^a   Kashiwase, Koichi ^b   Matsuo, Keitaro ^c   Azuma, Fumihiro ^b   Morishima, Satoko ^d   Onizuka, Makoto ^e   Yabe, Toshio ^b   Murata, Makoto ^f   Doki, Noriko ^g   Eto, Tetsuya ^h   Mori, Takehiko ⁱ   Miyamura, Koichi ^j   Sao, Hiroshi ^k   Ichinohe, Tatsuo ^l   Saji, Hiroo ^m   Kato, Shunichi ^e   Atsuta, Yoshiko ^f,n   Kawa, Keisei ^o   Kodera, Yoshihisa ^p   Sasazuki, Takehiko ^q  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b Kanto Koshinetsu Block Blood Center   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^h HAMANOMACHI HOSPITAL   (Japan)

ⁱ KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^k Meitetsu Hospital   (Japan)

^l HIROSHIMA UNIVERSITY   (Japan)

^m Japanese Red Cross Kanto Koshinetsu Block Blood Center   (Japan)

ⁿ JAPANESE DATA CENTER FOR HEMATOPOIETIC CELL TRANSPLANTATION   (Japan)

^o Japanese Red Cross Kinki Block Blood Centre   (Japan)

^p AICHI MEDICAL UNIVERSITY   (Japan)

^q KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; MELPHALAN; METHOTREXATE; TACROLIMUS; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA-DPB1 ANTIGEN; HLA-DQB1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLELE; ARTICLE; ATTRIBUTABLE RISK; BIOLOGICAL ACTIVITY; BONE MARROW TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; GENE LOCUS; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; IMMUNE RESPONSE; JAPANESE (PEOPLE); LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; UNRELATED DONORS; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; CHILD; GENETICS; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INFANT; LEUKEMIA; MIDDLE AGED; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLELES; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC LOCI; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DP BETA-CHAINS; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA; MALE; MIDDLE AGED; UNRELATED DONORS; YOUNG ADULT;

EID: 84923291695     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-10-604785     Document Type: Article

References (40)

1. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328(9):593-602.
2. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med. 1998;339(17):1177-1185.
3. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92(10):3515-3520.
4. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99(11):4200-4206.
5. Morishima Y, Yabe T, Matsuo K, et al Japan Marrow Donor Program. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transplant. 2007;13(3):315-328.
6. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7):1923-1930.
7. Lee SJ, Klein J, Haagenson M, et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583.
8. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110(13):4560-4566.
9. Fürst D, Müller C, Vucinic V, et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. Blood. 2013;122(18):3220-3229.
10. th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Int J Immunogenet. 2013;40(1):2-10.
11. Pidala J, Lee SJ, Ahn KW, et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood. 2014;124(16):2596-2606.
12. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med. 2007;4(1):e8.
13. Morishima S, Ogawa S, Matsubara A, et al Japan Marrow Donor Program. Impact of highly conserved HLA haplotype on acute graft-versus-host disease. Blood. 2010;115(23):4664-4670.
14. Kawase T, Morishima Y, Matsuo K, et al Japan Marrow Donor Program. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007;110(7):2235-2241.
15. Pidala J, Wang T, Haagenson M, et al. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood. 2013;122(22):3651-3658.
16. Fleischhauer K, Shaw BE, Gooley T, et al International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol. 2012;13(4):366-374.
17. Atsuta Y, Suzuki R, Yoshimi A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86(3):269-274.
18. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18(4):295-304.
19. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15(6):825-828.
20. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204-217.
21. Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291-455.
22. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695-706.
23. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:187-220.
24. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
25. Kawase T, Matsuo K, Kashiwase K, et al Japan Marrow Donor Program. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood. 2009;113(12):2851-2858.
26. Yabe T, Matsuo K, Hirayasu K, et al Japan Marrow Donor Program. Donor killer immunoglobulin-like receptor (KIR) genotypepatient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligandmismatched T cell-replete unrelated bone marrow transplantation. Biol Blood Marrow Transplant. 2008;14(1):75-87.
27. Fernández-Viña MA, Klein JP, Haagenson M, et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 2013;121(22):4603-4610.
28. Loiseau P, Busson M, Balere ML, et al. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant. 2007;13(8):965-974.
29. Kanda Y, Kanda J, Atsuta Y, et al. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation. Br J Haematol. 2013;161(4):566-577.
30. Morishima Y, Kawase T, Malkki M, et al International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19(8):1197-1203.
31. Petersdorf EW, Malkki M, Gooley TA, et al. MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation. Sci Transl Med. 2012;4(144):144ra101.
32. Petersdorf EW, Malkki M, Horowitz MM, Spellman SR, Haagenson MD, Wang T. Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation. Blood. 2013;121(10):1896-1905.
33. Harkensee C, Oka A, Onizuka M, et al Japan Marrow Donor Program. Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study. Blood. 2012;119(26):6365-6372.
34. Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M. Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. Biol Blood Marrow Transplant. 2012;18(11):1727-1733.
35. Horan J, Wang T, Haagenson M, et al. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. Blood. 2012;120(14):2918-2924.
36. Yagasaki H, Kojima S, Yabe H, et al Japan Marrow Donor Program. Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia. Blood. 2011;118(11):3186-3190.
37. Anasetti C, Logan BR, Lee SJ, et al Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367(16):1487-1496.
38. Atsuta Y, Morishima Y, Suzuki R, et al Japan Marrow Donor Program and Japan Cord Blood Bank Network. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Biol Blood Marrow Transplant. 2012;18(5):780-787.
39. Spellman SR, Eapen M, Logan BR, et al National Marrow Donor Program; Center for International Blood and Marrow Transplant Research. A perspective on the selection of unrelated donors and cord blood units for transplantation. Blood. 2012;120(2):259-265.
40. Morishima Y, Kawase T, Malkki M, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation Component. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens. 2007;69(suppl 1):31-35.